Recent Overview of the Use of iPSCs Huntington’s Disease Modeling and Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Overview of the Use of iPSCs Huntington’s Disease Modeling and Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 6, Pages 2239
Publisher
MDPI AG
Online
2020-03-24
DOI
10.3390/ijms21062239
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Altered Developmental Pathways in Human Juvenile HD iPSC With 71Q and 109Q Using Transcriptome Profiling
- (2019) Karolina Świtońska et al. Frontiers in Cellular Neuroscience
- Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
- (2019) Hongwon Kim et al. Stem Cell Reports
- Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
- (2019) Yi-Ying Wu et al. Open Biology
- Amelioration of Huntington’s disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington’s disease monkeys
- (2019) In Ki Cho et al. PLoS One
- Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEURON
- Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases
- (2019) Xinwen Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Organs to Cells and Cells to Organoids: The Evolution of in vitro Central Nervous System Modelling
- (2019) Dario Pacitti et al. Frontiers in Cellular Neuroscience
- Recent Progress in the Regeneration of Spinal Cord Injuries by Induced Pluripotent Stem Cells
- (2019) Maria Csobonyeiova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration
- (2019) Taras Ardan et al. Disease Models & Mechanisms
- iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery
- (2019) Gianluca Costamagna et al. Cells
- Human cellular models of medium spiny neuron development and Huntington disease
- (2018) Monika M. Golas LIFE SCIENCES
- An in vivo model of functional and vascularized human brain organoids
- (2018) Abed AlFatah Mansour et al. NATURE BIOTECHNOLOGY
- Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes
- (2018) P. Conforti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Shared effects of DISC1 disruption and elevated WNT signaling in human cerebral organoids
- (2018) Priya Srikanth et al. Translational Psychiatry
- Stem-cell culture moves to the third dimension
- (2018) C. Y. Tachibana NATURE
- From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases
- (2018) Matteo Bordoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microglia innately develop within cerebral organoids
- (2018) Paul R. Ormel et al. Nature Communications
- FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington’s disease and their derived neural cells
- (2017) Yanying Liu et al. HUMAN MOLECULAR GENETICS
- CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
- (2017) Nivya Kolli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
- (2017) Alex Mas Monteys et al. MOLECULAR THERAPY
- Fused cerebral organoids model interactions between brain regions
- (2017) Joshua A Bagley et al. NATURE METHODS
- Differentiation of human and murine induced pluripotent stem cells to microglia-like cells
- (2017) Hetal Pandya et al. NATURE NEUROSCIENCE
- The use of brain organoids to investigate neural development and disease
- (2017) Elizabeth Di Lullo et al. NATURE REVIEWS NEUROSCIENCE
- Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells
- (2017) M.-Y. Son et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders
- (2017) Derek K. Smith et al. PROGRESS IN NEUROBIOLOGY
- An Organoid-Based Model of Cortical Development Identifies Non-Cell-Autonomous Defects in Wnt Signaling Contributing to Miller-Dieker Syndrome
- (2017) Vira Iefremova et al. Cell Reports
- Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease
- (2017) Abeer Al-Gharaibeh et al. Frontiers in Neuroscience
- Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9
- (2016) Jun Wan Shin et al. HUMAN MOLECULAR GENETICS
- Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons
- (2016) Evgeny D. Nekrasov et al. Molecular Neurodegeneration
- Induced Pluripotent HD Monkey Stem Cells Derived Neural Cells for Drug Discovery
- (2016) Tanut Kunkanjanawan et al. SLAS Discovery
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’s Disease Phenotypes
- (2016) Waseem K. Raja et al. PLoS One
- Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation
- (2015) Takanori Takebe et al. Cell Stem Cell
- Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway
- (2015) Wojciech J. Szlachcic et al. Disease Models & Mechanisms
- Elucidating the role of the A2Aadenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs
- (2015) Feng-Lan Chiu et al. HUMAN MOLECULAR GENETICS
- Human pluripotent stem cell-derived neural constructs for predicting neural toxicity
- (2015) Michael P. Schwartz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Huntington disease
- (2015) Gillian P. Bates et al. Nature Reviews Disease Primers
- Personalized gene silencing therapeutics for Huntington disease
- (2014) C. Kay et al. CLINICAL GENETICS
- Cell-based therapies for Huntington's disease
- (2014) Yiju Chen et al. DRUG DISCOVERY TODAY
- Generation of cerebral organoids from human pluripotent stem cells
- (2014) Madeline A Lancaster et al. Nature Protocols
- Reversal of Cellular Phenotypes in Neural Cells Derived from Huntington’s Disease Monkey-Induced Pluripotent Stem Cells
- (2014) Richard L. Carter et al. Stem Cell Reports
- A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons
- (2013) Dawei Zhang et al. BIOMATERIALS
- Modeling neurodegenerative diseases in Caenorhabditis elegans
- (2013) Jia Li et al. EXPERIMENTAL NEUROLOGY
- Inhibition of mitochondrial fragmentation diminishes Huntington’s disease–associated neurodegeneration
- (2013) Xing Guo et al. JOURNAL OF CLINICAL INVESTIGATION
- Modeling Huntington's disease with induced pluripotent stem cells
- (2013) Julia A. Kaye et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Cerebral organoids model human brain development and microcephaly
- (2013) Madeline A. Lancaster et al. NATURE
- Human Pluripotent Stem Cell Differentiation into Authentic Striatal Projection Neurons
- (2013) Alessia Delli Carri et al. Stem Cell Reviews and Reports
- Choosing and usingDrosophilamodels to characterize modifiers of Huntington's disease
- (2012) Edward W. Green et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
- (2012) Mahru C. An et al. Cell Stem Cell
- Pluripotent Stem Cells Models for Huntington's Disease: Prospects and Challenges
- (2012) Richard L. Carter et al. Journal of Genetics and Genomics
- Mouse Models of Polyglutamine Diseases: Review and Data Table. Part I
- (2012) Maciej Figiel et al. MOLECULAR NEUROBIOLOGY
- Mouse Models of Polyglutamine Diseases in Therapeutic Approaches: Review and Data Table. Part II
- (2012) Pawel M. Switonski et al. MOLECULAR NEUROBIOLOGY
- The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
- (2012) Stefano Camnasio et al. NEUROBIOLOGY OF DISEASE
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells
- (2012) Tarja A Juopperi et al. Molecular Brain
- Using non-coding small RNAs to develop therapies for Huntington's disease
- (2011) Y Zhang et al. GENE THERAPY
- Oligonucleotide therapeutic approaches for Huntington disease
- (2011) Dinah W.Y. Sah et al. JOURNAL OF CLINICAL INVESTIGATION
- Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin
- (2011) Jeffrey B Carroll et al. MOLECULAR THERAPY
- Somatic coding mutations in human induced pluripotent stem cells
- (2011) Athurva Gore et al. NATURE
- Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs
- (2010) Dongshan Yang et al. HUMAN MOLECULAR GENETICS
- Sustained effects of nonallele-specificHuntingtinsilencing
- (2009) Valérie Drouet et al. ANNALS OF NEUROLOGY
- A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntingtons Disease
- (2008) Patrizia Popoli et al. CURRENT PHARMACEUTICAL DESIGN
- Towards a transgenic model of Huntington’s disease in a non-human primate
- (2008) Shang-Hsun Yang et al. NATURE
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
- (2008) J. L. McBride et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now